Skip to main content
Top
Published in: Tobacco Induced Diseases 1/2015

Open Access 01-12-2015 | Research

Factors associated with experimentation of electronic cigarettes among Parisian teenagers in 2013

Authors: Bertrand Dautzenberg, Ivan Berlin, Marie-Laure Tanguy, Nicole Rieu, Pierre Birkui

Published in: Tobacco Induced Diseases | Issue 1/2015

Login to get access

Abstract

Background

Electronic cigarettes (e-cig.) became widely used among adults. Data are insufficient about e-cig. experimentation among youth.

Methods

To assess prevalence of e-cig. experimentation and associated factors among the 12 to 19 years old we analyse a cross sectional school based survey in the city of Paris, France in 2013 on a randomly selected sample of 2 % of schoolchildren (n = 3 279). Self-report questionnaire include demographic, individual and family smoking characteristics and questions about e-cig: “Have you ever used an e-cigarette?”-Did you use e-cigarette in the last 30 days?”-“Did you try e-cigarette as a first tobacco product?

Results

In 2013, 17.9 % (564) schoolchildren reported having experienced the e-cig (boys: 19.0 %, girls: 16.8 %) compared to 9.8 % in 2012. Experimentation rate increases from 5 % among the 12 to 30 % among the 16-year-old. E-cig. experimentation was significantly associated with 11 parameters including : age >15 years (OR: 0.66 (IC95 % = 0.46–0.94)); smoking 10 cigarettes or more (OR = 5.67 (IC95 % = 3.11–10.34)), best friends and siblings smoker (OR = 1.54 (IC95 % = 1.11–2.14)) and (OR = 1.88 (IC95 % = 1.41–2.52)); experimentation of shisha (OR = 2.60 (IC95 % = 1.75–3.86)), cannabis use (OR = 1.90 (IC95 % = 1.32–2.72)); having two parents who forbid smoking (OR = 2.32 (IC95 % = 1.63–3.30)). Only 5.6 % of the study population (and 32.5 % of e-cig. experimenters (183/564)) have used it in the last 30 days; 1.7 % of the study population and 10.0 % of e-cig. experimenters were non-smokers (56/564).

Conclusions

Rate of e-cig. experimentation among schoolchildren increased by 8.1 % in 1 year. Non-smoking youth may use e-cig. Prospective studies are urgently needed to assess the evolution of e-cig. use both among smoking and non-smoking youth.
Literature
2.
go back to reference Polosa R, Morjaria JB, Caponnetto P, Campagna D, Russo C, Alamo A, et al. Effectiveness and tolerability of electronic cigarette in real-life:a 24-month prospective observational study. Intern Emerg Med. 2014;20:537–46.CrossRef Polosa R, Morjaria JB, Caponnetto P, Campagna D, Russo C, Alamo A, et al. Effectiveness and tolerability of electronic cigarette in real-life:a 24-month prospective observational study. Intern Emerg Med. 2014;20:537–46.CrossRef
6.
7.
go back to reference Neuberger M. The electronic cigarette: a wolf in sheep’s clothing. Wien Klin Wochenschr. 2015;127:385–7.CrossRefPubMed Neuberger M. The electronic cigarette: a wolf in sheep’s clothing. Wien Klin Wochenschr. 2015;127:385–7.CrossRefPubMed
10.
go back to reference Dautzenberg B, Birkui P, Noël M, Dorsett J, Osman M, Dautzenberg MD. Electronic cigarette: a new tobacco product for schoolchildren in Paris. Open J Respir Dis. 2013;3:21–4.CrossRef Dautzenberg B, Birkui P, Noël M, Dorsett J, Osman M, Dautzenberg MD. Electronic cigarette: a new tobacco product for schoolchildren in Paris. Open J Respir Dis. 2013;3:21–4.CrossRef
12.
go back to reference Cho JH, Shin E, Moon SS. Electronic-cigarette smoking experience among adolescents. J Adolesc Health. 2011;49:542–674.CrossRefPubMed Cho JH, Shin E, Moon SS. Electronic-cigarette smoking experience among adolescents. J Adolesc Health. 2011;49:542–674.CrossRefPubMed
13.
go back to reference Dutra LM, Glantz AS. Electronic cigarettes and conventional cigarette use among US adolescents. A cross-sectional study. JAMA pediatrics. 2014;168:610–7.PubMedCentralCrossRefPubMed Dutra LM, Glantz AS. Electronic cigarettes and conventional cigarette use among US adolescents. A cross-sectional study. JAMA pediatrics. 2014;168:610–7.PubMedCentralCrossRefPubMed
14.
go back to reference Goniewicz ML, Zielinska-Danch W. Electronic cigarette use among teenagers and young adults in Poland. Pediatrics. 2012;130:e879–85.CrossRefPubMed Goniewicz ML, Zielinska-Danch W. Electronic cigarette use among teenagers and young adults in Poland. Pediatrics. 2012;130:e879–85.CrossRefPubMed
15.
16.
go back to reference Kralikova E, Kubatova S, Truneckova K, Kmetova A, Hajek P. The electronic cigarette:what proportion of smokers has tried it and how many use it regularly? Addiction. 2012;107:1528–9.CrossRefPubMed Kralikova E, Kubatova S, Truneckova K, Kmetova A, Hajek P. The electronic cigarette:what proportion of smokers has tried it and how many use it regularly? Addiction. 2012;107:1528–9.CrossRefPubMed
17.
go back to reference King BA, Alam S, Promoff G, Arrazola R, Dube SR. Awareness and ever use of electronic cigarettes among U.S. adults, 2010–2011. Nicotine Tob Res. 2013;18:1623–7.CrossRef King BA, Alam S, Promoff G, Arrazola R, Dube SR. Awareness and ever use of electronic cigarettes among U.S. adults, 2010–2011. Nicotine Tob Res. 2013;18:1623–7.CrossRef
18.
go back to reference Adkison SE, O’Connor RJ, Bansal-Travers M, Hyland A, Borland R, Yong HH, et al. Electronic nicotine delivery systems: international tobacco control four- country survey. Am J Prev Med. 2013;44:207–15.PubMedCentralCrossRefPubMed Adkison SE, O’Connor RJ, Bansal-Travers M, Hyland A, Borland R, Yong HH, et al. Electronic nicotine delivery systems: international tobacco control four- country survey. Am J Prev Med. 2013;44:207–15.PubMedCentralCrossRefPubMed
Metadata
Title
Factors associated with experimentation of electronic cigarettes among Parisian teenagers in 2013
Authors
Bertrand Dautzenberg
Ivan Berlin
Marie-Laure Tanguy
Nicole Rieu
Pierre Birkui
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue 1/2015
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/s12971-015-0065-4

Other articles of this Issue 1/2015

Tobacco Induced Diseases 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine